Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation
出版年份 2016 全文链接
标题
Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2016-10-26
DOI
10.3389/fmicb.2016.01713
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mcr-1.2, a NewmcrVariant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512
- (2016) Vincenzo Di Pilato et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxins: a new hope in combating Gram-negative superbugs?
- (2016) Tony Velkov et al. Future Medicinal Chemistry
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- Bacteriocins and their position in the next wave of conventional antibiotics
- (2015) Veronica L. Cavera et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Bioengineering Lantibiotics for Therapeutic Success
- (2015) Des Field et al. Frontiers in Microbiology
- Bioengineering of the model lantibiotic nisin
- (2015) Des Field et al. Bioengineered
- A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius
- (2015) Des Field et al. PLoS One
- A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms
- (2014) Fany Reffuveille et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Quorum Sensing Inhibitors as Anti-Biofilm Agents
- (2014) Gilles Brackman et al. CURRENT PHARMACEUTICAL DESIGN
- Evaluation of nisin–β-lactam antibiotics against clinical strains of Salmonella enterica serovar Typhi
- (2014) Praveen Rishi et al. JOURNAL OF ANTIBIOTICS
- Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides
- (2014) Sibel Dosler et al. PEPTIDES
- An In Vitro Study on the Effects of Nisin on the Antibacterial Activities of 18 Antibiotics against Enterococcus faecalis
- (2014) Zhongchun Tong et al. PLoS One
- Synergistic Effect between Colistin and Bacteriocins in Controlling Gram-Negative Pathogens and Their Potential To Reduce Antibiotic Toxicity in Mammalian Epithelial Cells
- (2013) Karim Naghmouchi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of Fosfomycin, Tigecycline, Colistin, and Gentamicin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Foreign-Body Infection Model
- (2013) Stéphane Corvec et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Bacteriocins on Methicillin-Resistant Staphylococcus aureus Biofilm
- (2013) Ken-ichi Okuda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacology of polymyxins: new insights into an ‘old’ class of antibiotics
- (2013) Tony Velkov et al. Future Microbiology
- Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics
- (2013) Geneviève LeBel et al. PEPTIDES
- Intensive Mutagenesis of the Nisin Hinge Leads to the Rational Design of Enhanced Derivatives
- (2013) Brian Healy et al. PLoS One
- In vitro Activities of Nisin Alone or in Combination with Vancomycin and Ciprofloxacin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains
- (2012) Sibel Dosler et al. CHEMOTHERAPY
- ‘Old’ antibiotics for emerging multidrug-resistant bacteria
- (2012) Phillip J. Bergen et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Prevention of Staphylococcus aureus biofilm formation and reduction in established biofilm density using a combination of phage K and modified derivatives
- (2012) D. Kelly et al. LETTERS IN APPLIED MICROBIOLOGY
- Bacteriocins — a viable alternative to antibiotics?
- (2012) Paul D. Cotter et al. NATURE REVIEWS MICROBIOLOGY
- Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens
- (2012) Des Field et al. PLoS One
- Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action
- (2012) Jean Carlet et al. Antimicrobial Resistance and Infection Control
- Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)
- (2011) A. C. Gales et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibiotic and antimicrobial peptide combinations: synergistic inhibition of Pseudomonas fluorescens and antibiotic-resistant variants
- (2011) Karim Naghmouchi et al. RESEARCH IN MICROBIOLOGY
- Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V
- (2010) Des Field et al. Microbial Biotechnology
- Colistin in the 21st century
- (2009) Roger L Nation et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Lantibiotics: Mode of Action, Biosynthesis and Bioengineering
- (2009) G. Bierbaum et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species
- (2009) C. Piper et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structure−Activity Relationships of Polymyxin Antibiotics
- (2009) Tony Velkov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Polymyxins Revisited
- (2008) D. Landman et al. CLINICAL MICROBIOLOGY REVIEWS
- Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
- (2008) J. Overhage et al. INFECTION AND IMMUNITY
- Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients
- (2008) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More